UBS Group
IMA

UBS Group’s ImageneBio Inc IMA Stock Holding History

UBS Group’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.6K Buy
6,879
+1,451
+27% +$8.19K ﹤0.01% 7688
2026
Q1 		$27.1K Buy
5,428
+467
+9% +$3.03K ﹤0.01% 7755
2025
Q4 		$34.2K Buy
4,961
+191
+4% +$1.42K ﹤0.01% 7447
2025
Q3 		$38.9K Sell
4,770
-1,452
-23% -$19.2K ﹤0.01% 7737
2025
Q2 		$100K Sell
6,222
-2,166
-26% -$31.8K ﹤0.01% 7239
2025
Q1 		$129K Buy
8,388
+2,400
+40% +$41.4K ﹤0.01% 6847
2024
Q4 		$118K Buy
5,988
+5,982
+99,700% +$121K ﹤0.01% 6772
2024
Q3 		$125 Sell
6
-3,479
-100% -$70.4K ﹤0.01% 9134
2024
Q2 		$69K Buy
3,485
+756
+28% +$13.3K ﹤0.01% 6439
2024
Q1 		$46.5K Buy
2,729
+971
+55% +$17.7K ﹤0.01% 6543
2023
Q4 		$41.5K Buy
1,758
+620
+54% +$20.2K ﹤0.01% 6654
2023
Q3 		$59.1K Buy
1,138
+109
+11% +$6.56K ﹤0.01% 6191
2023
Q2 		$81K Buy
1,029
+977
+1,879% +$70.1K ﹤0.01% 6170
2023
Q1 		$2.15K Buy
+52
New +$2.39K ﹤0.01% 8564
2021
Q4 		– Sell
-7
Closed -$1K – 10463
2021
Q3 		$1K Buy
+7
New +$1.02K ﹤0.01% 9191
2021
Q2 		– Sell
-81
Closed -$27K – 9570
2021
Q1 		$27K Buy
+81
New +$27.7K ﹤0.01% 7095

Other funds holding IMA

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group's IMA Position: Q2 2026 in Review

UBS Group increased its ImageneBio Inc (IMA) stake by 27% in Q2 2026, buying an estimated $8.19K and bringing the position to 6,879 shares worth $40.6K. The position accounts for ﹤0.01% of the portfolio, ranked #7688.

UBS Group first reported a position in IMA in Q1 2021 and has held it in 16 quarters since. The position peaked at $129K in Q1 2025. 17 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • UBS Group held 6,879 shares of ImageneBio Inc worth $40.6K as of Q2 2026.
  • UBS Group bought 1,451 ImageneBio Inc shares in Q2 2026, an estimated $8.19K.
  • ImageneBio Inc made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7688 holding.
  • UBS Group first reported a position in ImageneBio Inc in Q1 2021 and has held it in 16 quarters since.
  • UBS Group's ImageneBio Inc position peaked at $129K in Q1 2025.
  • 17 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.